human
interferon
ifn
induc
mxa
protein
key
antivir
host
restrict
factor
exhibit
broad
antivir
activ
mani
rna
virus
includ
highli
pathogen
avian
influenza
virus
iav
subtyp
date
mechan
mxa
exert
antivir
activ
unclear
howev
addit
cellular
factor
believ
essenti
activ
identifi
mxa
cofactor
perform
genomewid
sirnabas
screen
human
airway
epitheli
cell
constitut
express
mxa
use
report
viru
data
complement
proteom
screen
identifi
mxainteract
protein
combin
data
identifi
atpas
subunit
baf
chromatin
remodel
complex
crucial
factor
requir
antivir
activ
mxa
iav
intriguingli
data
demonstr
although
essenti
express
ifnstimul
gene
isg
establish
antivir
state
requir
express
mxa
suggest
indirect
effect
mxa
activ
transcriptom
analysi
cell
identifi
small
set
factor
requir
activ
mxa
particular
find
reveal
sever
virusinduc
factor
work
concert
enabl
mxa
restrict
iav
np
made
import
nucleu
viral
polymeras
switch
synthesi
complementari
rna
encapsid
complementari
rnp
crnp
process
crnp
turn
serv
intermedi
synthesi
new
vrnp
final
export
nucleu
packag
new
viral
particl
plasma
membran
intact
innat
immun
respons
critic
restrict
viral
replic
surviv
exemplifi
anim
experi
also
sever
diseas
progress
seen
young
children
mutat
crucial
innat
immun
gene
recognit
pathogenassoci
molecular
pattern
viral
rna
cell
respond
secret
type
iii
interferon
interferon
bind
respect
receptor
lead
jakstat
signal
eventu
induct
sever
hundr
interferonstimul
gene
isg
direct
effector
activ
particular
virus
speed
antivir
respons
critic
prevent
viru
spread
therefor
isg
promot
would
otherwis
cover
nucleosom
avail
immedi
access
prime
rapid
transcript
activ
bound
swisnf
chromatin
remodel
complex
baf
complex
promotorbound
baf
complex
facilit
rapid
induct
also
basal
level
express
upon
stimul
induct
isg
higher
extent
among
mani
isg
human
mxa
shown
particularli
potent
inhibit
iav
replic
vitro
well
vivo
import
emphas
fact
humanadapt
iav
includ
pandem
virus
evolv
partial
resist
toward
mxa
antivir
activ
mutat
np
mxa
belong
famili
larg
dynaminlik
gtpase
local
cytoplasm
contrast
iav
replic
occur
nucleu
date
mechan
mxa
inhibit
iav
replic
still
unclear
somewhat
controversi
howev
gener
agreement
earli
step
iav
replic
cycl
affect
avian
influenza
virus
includ
subtyp
highli
sensit
mxa
find
humanadapt
iav
abl
partial
escap
antivir
effect
mxa
mutat
np
suggest
restrict
might
mediat
direct
physic
bind
iav
np
mxa
howev
np
close
relat
thogoto
viru
thov
coprecipit
mxa
similar
approach
iav
np
fail
show
convinc
interact
therefor
hypothes
iav
npmxa
interact
low
affin
may
requir
presenc
addit
host
cell
factor
thov
replic
shown
inhibit
mxa
block
nuclear
transloc
incom
vrnp
xiao
colleagu
recent
demonstr
similar
mode
action
might
appli
iav
vrnp
howev
experiment
setup
requir
ifn
pretreat
addit
mxa
overexpress
suggest
addit
isg
requir
mxa
restrict
influenza
virus
line
relat
human
paralog
mxa
mxb
similarli
depend
host
cell
factor
activ
lose
abil
prevent
viral
dna
enter
nucleu
integr
genom
absenc
cyclophilin
conduct
genomewid
sirna
screen
proteom
screen
identifi
potenti
mxa
cofactor
requir
antivir
activ
human
mxa
identifi
essenti
antivir
effect
mxa
virus
atpas
subunit
swisnf
chromatin
remodel
complex
baf
complex
complex
known
resid
promot
mani
isg
therebi
facilit
induct
data
show
requir
induct
antivir
state
ifntreat
cell
induct
mxa
per
se
affect
absenc
transcriptom
analysi
cell
identifi
larg
number
gene
mani
isg
sever
factor
particular
requir
effici
inhibit
viral
replic
cell
therefor
data
demonstr
sever
isg
act
concert
facilit
antivir
activ
mxa
influenza
virus
influenza
virus
iav
sever
human
pathogen
origin
avian
reservoir
humanadapt
iav
caus
annual
epidem
rare
also
caus
pandem
million
peopl
succumb
infect
recent
emerg
bird
flu
virus
subtyp
fatal
rate
among
human
rang
rais
concern
avian
virus
might
acquir
abil
transmit
humantohuman
initi
next
pandem
influenza
virus
segment
rna
genom
neg
polar
genom
segment
organ
viral
ribonucleoprotein
vrnp
consist
viral
rna
three
polymeras
subunit
pa
viral
nucleoprotein
np
requir
encapsid
viral
rna
follow
viru
entri
viral
np
mediat
rapid
nuclear
transloc
vrnp
properti
enabl
iav
evad
cytosol
pattern
recognit
receptor
grant
access
nuclear
splice
machineri
requir
express
certain
viral
gene
initi
iav
polymeras
synthes
mrna
transcript
translat
viral
protein
cytosol
ribosom
suffici
amount
newli
synthes
viral
protein
particular
pa
identif
host
cell
factor
requir
antivir
activ
mxa
identifi
factor
requir
antivir
activ
mxa
develop
genomewid
sirna
screen
assay
wellestablish
human
lung
epitheli
cell
line
stabli
overexpress
human
mxa
easili
monitor
viru
replic
report
viru
gener
base
highli
mxasensit
influenza
viru
incorpor
renilla
rl
luciferas
report
construct
ns
segment
previous
describ
reuther
colleagu
supplementari
figur
furthermor
allow
util
highli
pathogen
avian
influenza
hpai
viru
biosafeti
level
condit
sever
posit
charg
amino
acid
remov
hemagglutinin
ha
cleavag
site
render
monobas
thu
classifi
viru
low
pathogen
avian
viru
supplementari
figur
presenc
mxa
viru
replic
inhibit
result
low
level
rl
activ
upon
transfect
sirna
target
mxa
silenc
mxaencod
gene
viru
replic
restor
increas
rl
activ
observ
supplementari
figur
goal
sirna
screen
identifi
sirna
restor
viru
replic
presenc
mxa
serv
posit
control
nontarget
nt
sirna
neg
control
assay
miniatur
format
qualiti
assess
measur
strictli
standard
mean
differ
ssmd
account
assay
window
variabl
ssmd
calcul
confirm
high
qualiti
assay
suitabl
highthroughput
screen
supplementari
figur
array
genomewid
sirna
librari
sirna
pool
sirna
per
gene
target
total
human
gene
transfect
cell
triplic
hour
post
transfect
cell
infect
report
viru
multipl
infect
moi
h
later
luciferas
activ
determin
util
renillaglo
promega
substrat
fig
ssmd
use
valid
qualiti
plate
ssmd
hit
select
base
averag
zscore
across
triplic
supplementari
figur
c
result
identif
primari
hit
supplementari
tabl
offtarget
effect
hit
valid
secondari
sirna
screen
individu
transfect
sirna
pool
supplementari
figur
ssmd
use
valid
plate
result
analyz
use
redund
sirna
activ
rsa
statist
analysi
assign
pvalu
gene
base
effect
four
sirna
hit
select
base
pvalu
use
method
identifi
gene
includ
mxaencod
gene
whose
knockdown
led
signific
pvalu
increas
viru
growth
cell
supplementari
tabl
identif
host
cell
factor
physic
associ
mxa
parallel
rnaimedi
approach
identifi
host
factor
requir
mxa
activ
employ
second
strategi
aim
identifi
host
cell
factor
interact
mxa
experiment
condit
larg
maintain
allow
combin
bioinformat
analysi
sirna
screen
proteom
screen
data
later
step
antivir
activ
mx
protein
affect
addit
aminotermin
tag
therefor
cell
express
aminotermin
streptavidintag
mxa
strepmxa
control
doxycyclineinduc
promot
gener
alongsid
control
cell
express
strepgfp
strepmxa
strepgfp
induc
doxycyclin
hour
cell
either
infect
mock
infect
triplic
hour
post
infect
cell
lyse
streptag
protein
precipit
affin
purif
streptactin
sepharos
bead
precipit
protein
digest
identifi
mass
fig
supplementari
figur
mass
spectrometri
file
search
use
maxquant
statist
analysi
perform
use
msstat
none
factor
virusencod
host
cell
factor
qualifi
highconfid
hit
base
enrich
mxa
bait
vs
gfp
bait
infect
pvalu
statist
condit
minim
fals
neg
pvalu
statist
condit
minim
fals
posit
supplementari
tabl
bioinformat
analysi
combin
rnai
proteom
dataset
genom
proteom
screen
identifi
host
cell
factor
respect
although
comparison
result
hit
show
direct
overlap
use
ingenu
pathway
analysi
ipa
qiagen
abl
identifi
network
host
cell
factor
supplementari
tabl
includ
mxa
significantli
enrich
amongst
dataset
analyz
represent
canon
pathway
upstream
regul
proteinprotein
interact
network
pvalu
fig
supplementari
figur
within
network
factor
includ
mxa
identifi
sirna
screen
proteom
screen
valid
requir
factor
mxa
antivir
activ
transfect
cell
sirna
target
respect
gene
sirna
per
gene
follow
infect
luciferas
activ
measur
assess
antivir
effect
consid
factor
valid
least
sirna
significantli
increas
viru
replic
pvalu
compar
nontarget
nt
control
sirna
supplementari
figur
criteria
met
also
known
zap
data
gener
presenc
mxa
suggest
requir
effici
mxa
restrict
howev
may
also
antivir
effect
independ
mxa
antivir
role
presenc
mxa
restrict
factor
broad
antivir
spectrum
howev
activ
iav
modest
inform
relev
mxa
restrict
similarli
initi
caspas
requir
apoptot
pathway
neither
associ
mxa
iav
shown
atpas
subunit
baf
chromatin
remodel
complex
complex
requir
induct
mani
gene
includ
interferonstimul
gene
isg
antiiav
activ
verifi
requir
antivir
activ
mxa
act
mxaindepend
restrict
factor
made
use
wild
type
cell
establish
cell
line
stabli
overexpress
short
hairpin
rna
target
mxa
shmxa
due
stabl
express
shmxa
even
mxa
induc
viral
infect
expect
immedi
silenc
upon
infect
renillaexpress
report
viru
base
mxasensit
iav
strain
high
report
activ
observ
cell
replic
consider
reduc
cell
due
presenc
mxa
supplementari
figur
sirna
knockdown
mxa
increas
report
activ
virus
least
cell
sirna
increas
report
activ
fig
supplementari
figur
hand
cell
increas
observ
upon
rnaimedi
deplet
data
suggest
mxa
requir
presenc
effici
restrict
influenza
virus
absenc
mxa
display
antivir
properti
requir
antivir
activ
mxa
context
report
viru
also
wild
type
viru
infect
perform
sirna
knockdown
infect
cell
cell
mxasensit
strain
moi
hour
post
infect
viral
titer
measur
plaqu
assay
knockdown
effici
determin
western
blot
analysi
fig
silenc
mxa
cell
elev
viru
titer
approxim
log
compar
cell
treat
nontarget
control
sirna
nt
viru
restrict
pfuml
due
mxa
overexpress
knockdown
use
effici
sirna
supplementari
figur
result
log
increas
viral
titer
rel
sint
cell
fig
combin
mxa
knockdown
result
increas
viral
titer
level
simxa
alon
similar
observ
wildtyp
report
virus
cell
fig
f
supplementari
figur
summari
data
confirm
requir
effici
antivir
activ
mxa
context
wild
type
viru
infect
requir
isg
induct
express
mxa
atpas
subunit
baf
chromatin
remodel
complex
complex
shown
chromatin
remodel
activ
either
conjunct
anoth
atpas
subunit
depend
develop
stage
cell
type
investig
hela
cell
baf
complex
shown
scientif
report
requir
induct
typei
interferonstimul
gene
isg
howev
cell
express
protein
supplementari
figur
ref
aim
investig
whether
involv
isg
express
cell
cell
transfect
sirna
target
mxa
treat
uml
h
sirna
transfect
h
ifn
treatment
cell
challeng
absenc
ifn
enhanc
viral
replic
observ
rel
nontarget
nt
control
sirna
fig
ifntreat
cell
howev
silenc
major
signal
transduc
ifn
signal
requir
ifnmedi
induct
isg
led
signific
increas
viral
replic
knockdown
singl
isg
mxa
elev
viral
replic
fig
intriguingli
knockdown
result
increas
viru
replic
suggest
inde
requir
establish
ifninduc
antivir
state
cell
one
explan
may
requir
mxa
express
along
isg
inde
case
knockdown
mxa
express
substanti
diminish
determin
western
blot
analysi
fig
surprisingli
deplet
alter
mxa
induct
ifn
find
lead
us
conclud
requir
robust
induct
isg
mxa
turn
support
antivir
activ
mxa
thu
absenc
cell
express
mxa
show
increas
suscept
iav
infect
analysi
cell
pretreat
uml
h
prior
infect
reveal
fact
tabl
gene
ontolog
go
term
enrich
analysi
reveal
dataset
highli
enrich
gene
categori
associ
ifn
alpha
gamma
respons
fig
line
previou
find
requir
establish
antivir
state
fig
total
gene
select
valid
base
extent
downregul
deplet
top
gene
log
fc
correspond
downregul
identif
isg
interferomeorg
cell
gene
log
fc
well
cell
line
gene
log
fc
anoth
handpick
gene
ad
includ
control
final
pseudogen
filter
investig
factor
requir
antivir
activ
mxa
sirna
pool
use
silenc
gene
cell
subsequ
infect
ensur
suffici
induct
select
factor
thu
allow
knockdown
cell
receiv
uml
h
prior
infect
minim
amount
found
reduc
viral
report
activ
indic
isg
induct
without
diminish
complet
supplementari
figur
none
sirna
cytotox
effect
supplementari
figur
effect
sirna
pool
viru
replic
ifn
determin
rank
accord
strongest
increas
viral
replic
green
absenc
ifn
fig
supplementari
figur
expect
although
gener
pattern
similar
greater
effect
observ
presenc
ifn
mxa
deplet
enhanc
replic
knockdown
sever
factor
display
clear
effect
increas
viral
replic
upon
silenc
promin
howev
knockdown
isg
result
increas
viral
replic
knockdown
hand
rel
known
potent
iav
restrict
factor
show
increas
viru
replic
mxa
overexpress
condit
absenc
mxa
cell
antivir
effect
visibl
stronger
cell
prestimul
ifn
fig
gener
replicationenhanc
effect
upon
knockdown
potent
factor
appear
depend
presenc
mxa
full
effect
minor
increas
report
activ
observ
cell
eg
fig
easili
assess
whether
factor
depend
mxa
calcul
ratio
rel
report
activ
cell
either
without
ifnpretreat
consid
factor
ratio
fig
factor
strongest
evid
mxa
cofactor
summari
data
identifi
sever
factor
particular
virusinduc
factor
requir
iav
restrict
mxa
mxa
gtpase
potent
ifninduc
restrict
factor
inhibit
earli
step
influenza
viru
iav
replic
cycl
absenc
mxa
ribonucleoproteinorgan
viral
genom
rapidli
transport
nucleu
viral
transcript
genom
replic
take
place
block
presenc
mxa
although
postul
remain
shown
whether
cellular
factor
involv
mediat
antivir
effect
mxa
therefor
conduct
parallel
rnai
protein
interact
screen
identifi
potenti
mxa
cofactor
identifi
network
factor
support
screen
focus
one
particular
factor
valid
requir
effici
mxa
restrict
iav
also
name
brm
one
two
mutual
exclus
atpas
subunit
evolutionari
highli
conserv
baf
chromatin
remodel
complex
also
known
swisnf
complex
shown
involv
regul
gene
express
cell
cycl
control
tumorigenesi
interestingli
human
lung
adenocarcinoma
cell
line
use
studi
express
atpas
subunit
loss
mutat
seem
rel
frequent
event
tumorigenesi
least
partial
compens
loss
suffic
say
use
cell
could
studi
role
specif
unabl
gener
crispr
knockout
cell
cell
prolifer
inhibit
agre
previou
report
howev
transient
knockdown
found
deplet
decreas
abil
ifntreat
cell
establish
antivir
state
agreement
previou
find
baf
complex
requir
induct
subset
gene
although
studi
focu
surprisingli
howev
mxa
express
unaffect
deplet
suggest
reduc
mxa
antivir
function
due
absenc
one
factor
flow
cytometri
experi
support
demonstr
deplet
lead
elev
number
cell
posit
viral
antigen
np
mxa
ifnpretr
cell
result
also
provid
strong
support
find
xiao
colleagu
addit
isg
requir
full
mxa
activ
show
isg
probabl
regul
altern
mxa
may
interact
although
unlik
neither
baf
compon
identifi
mxainteract
candid
mass
spectrometri
analysi
also
nuclear
protein
unlik
mxa
transcriptom
analysi
iavinfect
cell
identifi
gene
strongli
depend
presenc
far
significantli
enrich
gene
categori
responseassoci
gene
valid
import
isg
express
even
absenc
cui
colleagu
demonstr
hela
cell
constitut
bind
promot
isg
result
basal
level
express
rapid
strong
induct
upon
stimul
show
gene
regul
cell
final
determin
factor
requir
full
antivir
activ
mxa
applic
low
level
experi
allow
larger
assay
window
detect
isg
may
account
fail
detect
factor
primari
rnai
screen
intriguingli
host
cell
factor
isg
factor
induc
respons
ifn
viru
infect
cell
may
either
ifnor
virusinduc
expect
factor
display
antivir
activ
absenc
mxa
eg
other
seem
strictli
depend
presenc
mxa
nonetheless
case
iav
restrict
potenc
factor
increas
cell
antivir
activ
mxa
appear
reli
particularli
presenc
insulinlik
growth
factor
bind
protein
bind
insulinlik
growth
factor
circul
plasma
modul
growthpromot
effect
furthermor
interact
receptor
therebi
act
tumor
suppressor
intern
result
alter
cell
signal
unclear
could
increas
mxa
activ
studi
requir
determin
whether
act
isg
data
suggest
belong
protein
famili
interferoninduc
transmembran
protein
famili
known
import
iav
restrict
ifitm
protein
typei
typeii
ifninduc
cellintrins
restrict
factor
first
describ
antivir
function
alber
et
al
recent
signific
iav
restrict
discov
genomewid
sirna
screen
howev
ifitm
also
activ
mani
envelop
rna
virus
human
three
ifitm
ifninduc
display
antivir
properti
name
iav
restrict
mainli
mediat
similar
potenc
mxa
show
intermedi
phenotyp
demonstr
minor
effect
hcv
restrict
howev
play
domin
role
least
part
due
local
plasma
membran
case
believ
counteract
viral
fusion
plasma
membran
restrict
access
cytosol
similarli
differ
amino
acid
thought
block
fusion
iav
endosom
membran
therefor
main
mechan
restrict
ifitm
prevent
fusion
viral
membran
cellular
lipid
bilay
although
mechan
also
propos
demonstr
presenc
mxa
major
ifitm
member
requir
iav
restrict
interestingli
mxa
thought
restrict
iav
similar
stage
viru
life
cycl
describ
act
late
endosom
mxa
directli
releas
vrnp
late
endosom
furthermor
mxa
shown
associ
membran
therefor
conceiv
mxa
act
coordin
sequenti
fashion
similar
manner
recent
propos
narayana
et
al
studi
propos
ifitm
would
trap
viru
endocyt
pathway
eventu
redirect
lysosom
degrad
propos
mxa
might
cooper
small
extent
earli
endosom
strongli
late
endosom
shortli
vrnp
releas
intriguingli
narayana
colleagu
alreadi
hypothes
may
associ
unknown
host
factor
restrict
viral
replic
apart
sever
factor
also
found
show
stronger
antivir
effect
presenc
mxa
therefor
possibl
achiev
full
viral
inhibit
sever
identifi
factor
may
act
concert
well
mxa
studi
requir
investig
individu
contribut
factor
whether
certain
combin
need
fulli
support
antivir
activ
mxa
summari
studi
identifi
ifnor
virusinduc
host
factor
requir
full
antivir
activ
mxa
also
emphas
critic
role
chromatin
remodel
complex
antivir
immun
respons
cell
cultur
wild
type
human
cell
lung
carcinoma
atcc
cell
stabli
overexpress
mxa
cell
stabli
express
short
hairpin
rna
target
mxa
kindli
provid
richard
e
randal
univers
st
andrew
st
andrew
uk
cell
stabli
express
streptavidintag
mxa
streptavidintag
gfp
gener
describ
cultur
dmem
medium
fb
penicillinstreptomycin
canin
mdckii
cell
use
viru
titrat
cultur
condit
virus
recombin
viru
gener
describ
previous
renilla
luciferas
report
viru
harbor
multibas
ha
cleavag
site
obtain
publish
reuther
colleagu
briefli
splice
donor
splice
acceptor
site
ns
geneencod
sequenc
silenc
overlap
nep
open
read
frame
separ
renilla
luciferaseencod
sequenc
introduc
obtain
separ
gene
product
porcin
peptideencod
sequenc
introduc
orf
detail
descript
also
see
fig
procedur
appli
gener
renilla
luciferas
viru
howev
case
viru
encod
monobas
ha
cleavag
site
gener
alter
cleavag
site
describ
previous
recombin
virus
plaqu
purifi
mdckii
cell
viru
stock
either
prepar
mdckii
cell
day
old
embryon
chicken
egg
titer
determin
plaqu
assay
sirna
screen
primari
genomewid
screen
assess
role
gene
perform
use
sirna
pool
sirna
transfect
nontarget
sirna
ge
dharmacon
mxatarget
sirna
qiagen
serv
neg
posit
control
respect
cell
seed
plate
cellswel
revers
transfect
sirna
final
concentr
nm
use
transfect
reagent
plate
run
triplic
hour
cell
infect
renilla
luciferas
report
viru
moi
hour
luciferas
activ
analyz
ad
renilla
luciferas
substrat
renillaglo
luciferas
assay
system
promega
read
use
envis
multilabel
plate
reader
perkinelm
secondari
screen
perform
gene
individu
transfect
sirna
pool
use
primari
screen
rest
procedur
perform
describ
sirna
librari
plate
provid
ge
healthcar
dharmacon
inc
human
sigenom
smartpool
librari
sirna
resuspend
concentr
lysat
clarifi
centrifug
g
min
clear
supernat
retain
input
sampl
remain
ad
ip
buffer
mm
trishcl
mm
nacl
mm
edta
contain
equival
bead
volum
streptactin
sepharos
bead
iba
lifesci
affin
tag
bind
proceed
rotat
hour
bead
centrifug
g
minut
clear
supernat
retain
unbound
flow
sampl
remain
supernat
discard
bead
wash
twice
ip
buffer
contain
twice
ip
buffer
deterg
streptactinpurifi
protein
reduc
alkyl
bead
reductionalkyl
buffer
mm
trishcl
urea
mm
dtt
mm
iodoacetamid
incub
dark
minut
gentl
shake
addit
mm
dtt
ad
quench
reaction
protein
digest
trypsin
invitrogen
overnight
next
day
bead
centrifug
g
minut
peptidecontain
supernat
collect
formic
acid
ad
final
concentr
acidifi
peptid
peptid
desalt
use
agil
omix
tip
accord
manufactur
protocol
follow
modif
briefli
tip
condit
acetonitril
formic
acid
equilibr
two
rins
formic
acid
peptid
bound
repeat
pipet
rins
twice
formic
acid
elut
acetonitril
second
elut
acetonitril
use
ensur
complet
recoveri
peptid
dri
vacuum
centrifug
suspend
acetonitril
formic
acid
digest
peptid
subject
lcmsm
analysi
use
easynlc
coupl
dualpressur
linear
ion
trap
velo
pro
orbitrap
elit
mass
spectromet
thermo
fisher
scientif
san
jose
ca
onlin
lc
separ
perform
use
cm
fuse
silica
integrafrit
capillari
pack
reprosilpur
aq
reversedphas
resin
dr
maischgmbh
peptid
elut
gradient
acetonitril
formic
acid
minut
deliv
flow
rate
nlminut
cycl
one
full
ms
scan
mz
resolut
orbitrap
follow
datadepend
ms
ms
scan
fragment
normal
collis
energi
set
acquir
linear
ion
trap
target
ion
alreadi
acquir
msm
scan
dynam
exclud
second
raw
ms
file
analyz
maxquant
version
msm
spectra
search
andromeda
search
engin
databas
contain
swissprot
human
influenza
protein
sequenc
total
run
given
bait
analyz
simultan
maxim
match
run
algorithm
avail
maxquant
multipl
scientif
report
set
fals
discoveri
rate
impos
peptid
protein
identif
normal
raw
peptid
intens
protein
level
abund
infer
calcul
use
linear
mixedeffect
model
built
msstat
r
packag
version
protein
appear
singl
biolog
replic
exclud
analysi
network
analysi
result
genom
proteom
screen
combin
analyz
use
ingenu
pathway
analysi
ipa
qiagen
look
gene
ontolog
canon
pathway
regul
proteinprotein
interact
enrich
consid
term
pvalu
identifi
factor
present
enrich
categori
proteinprotein
interact
network
show
physic
interact
within
factor
also
gener
use
ipa
qiagen
sirna
valid
cell
seed
plate
cellswel
revers
transfect
sirna
use
lipofectamin
rnaimax
final
sirna
concentr
nm
hour
transfect
cell
infect
renilla
luciferas
report
viru
moi
hour
luciferas
activ
analyz
ad
luciferas
substrat
renillaglo
luciferas
assay
system
promega
per
well
read
use
glomax
multiplu
plate
reader
promega
infinit
micropl
reader
tecan
experi
perform
least
technic
triplic
bioinformat
analysi
rnaseq
illumina
hiseq
bp
singleend
read
rnaseq
librari
first
adaptor
trim
analyz
use
tophat
cufflink
softwar
tophat
util
align
short
read
refer
genom
analyz
gene
express
cufflink
util
transcript
assembl
differenti
express
cummerbund
visual
differenti
analysi
default
paramet
use
addit
method
found
supplementari
inform
data
avail
reagent
share
distribut
investig
upon
request
research
purpos
upon
sign
standard
materi
transfer
agreement
relev
institut
necessari
